1. Home
  2. BHVN vs SRCE Comparison

BHVN vs SRCE Comparison

Compare BHVN & SRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • SRCE
  • Stock Information
  • Founded
  • BHVN 2013
  • SRCE 1863
  • Country
  • BHVN United States
  • SRCE United States
  • Employees
  • BHVN N/A
  • SRCE N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • SRCE Major Banks
  • Sector
  • BHVN Health Care
  • SRCE Finance
  • Exchange
  • BHVN Nasdaq
  • SRCE Nasdaq
  • Market Cap
  • BHVN 1.5B
  • SRCE 1.5B
  • IPO Year
  • BHVN 2017
  • SRCE N/A
  • Fundamental
  • Price
  • BHVN $13.92
  • SRCE $63.77
  • Analyst Decision
  • BHVN Strong Buy
  • SRCE Hold
  • Analyst Count
  • BHVN 15
  • SRCE 3
  • Target Price
  • BHVN $56.07
  • SRCE $72.00
  • AVG Volume (30 Days)
  • BHVN 2.1M
  • SRCE 64.9K
  • Earning Date
  • BHVN 11-11-2025
  • SRCE 10-23-2025
  • Dividend Yield
  • BHVN N/A
  • SRCE 2.39%
  • EPS Growth
  • BHVN N/A
  • SRCE 10.56
  • EPS
  • BHVN N/A
  • SRCE 5.70
  • Revenue
  • BHVN N/A
  • SRCE $391,814,000.00
  • Revenue This Year
  • BHVN N/A
  • SRCE $17.85
  • Revenue Next Year
  • BHVN $2,002.87
  • SRCE $1.85
  • P/E Ratio
  • BHVN N/A
  • SRCE $11.16
  • Revenue Growth
  • BHVN N/A
  • SRCE 6.91
  • 52 Week Low
  • BHVN $12.79
  • SRCE $52.14
  • 52 Week High
  • BHVN $55.70
  • SRCE $68.13
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 41.13
  • SRCE 54.27
  • Support Level
  • BHVN $13.63
  • SRCE $63.30
  • Resistance Level
  • BHVN $17.05
  • SRCE $64.39
  • Average True Range (ATR)
  • BHVN 0.87
  • SRCE 1.13
  • MACD
  • BHVN -0.23
  • SRCE -0.04
  • Stochastic Oscillator
  • BHVN 8.01
  • SRCE 23.64

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About SRCE 1st Source Corporation

1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.

Share on Social Networks: